ENVALITH
コージンバイオ株式会社 logo

Kohjin Bio Co., Ltd.

177A・Growth Market・Chemicals

Official website
コージンバイオ株式会社 logo
Kohjin Bio Co., Ltd.177A
Reference Indicators

Market Cap

46¥100M

P/E (Forecast)

41.5x

P/B

0.8x

Dividend Yield (Forecast)

1.11%

ROE

4.3%

EV/EBITDA

5.4x
Financial Summary
Unit: ¥M
Item
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
4,7705,2064,939
Cost of Sales
2,8882,8403,081
Gross Profit
1,8812,3661,857
SG&A Expenses
1,2841,3741,515
Operating Income
596991341
Non-operating Income
9311759
Non-operating Expenses
544359
Ordinary Income
6351,065340
Extraordinary Income
—111
Extraordinary Losses
05120
Pre-tax Income
6351,015332
Income Taxes
25022081
Net Income
384794251
EBITDA
8961,352737
Gross Margin
39.4%45.4%37.6%
Operating Margin
12.5%19.0%6.9%
ROA
5.8%8.8%2.8%
ROE
12.1%17.4%4.3%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
組織培養事業2,53994637.3%
微生物事業1,424-94-6.6%
細胞加工事業974798.1%